Medtronic announces $2B debt offering
February 21, 2014 by Brad Perriello
Medtronic says it plans to offer $2 billion worth of senior notes
Medtronic (NYSE:MDT) said today that it plans to offer a total of $2 billion in senior debt notes next week.
The world’s largest pure-play medtech maker said it expects to issue $250 million in 0.9% notes due in 2017; another $250 million in floating rate notes due the same year; $850 million in 3.6% notes due in 2024; and $650 million in 4.6% notes due in 2044. Read more
Paradigm Spine lands $75 million in debt financing
February 21, 2014 by Chris Walker
Paradigm Spine inks a $75 million credit deal with PDL BioPharma it plans to use to refinance its existing credit and boost its U.S. commercial efforts.
Paradigm Spine said it inked a $75 million credit agreement with PDL BioPharma.
Paradigm Spine, which makes spinal implants, said it will take the 1st $50 million in at closing, with another $25 million in milestone-based payments on the table. Read more
Mayo Clinic team, tech entrepreneurs raise $1.1M for mobile data management
February 26, 2014 by Chris Walker
A Mayo Clinic academic clinical team links up with a group of tech entrepreneurs to start provide hospital data management.
A Mayo Clinic team and a group of seasoned technology entrepreneurs launched a new company called Ambient Clinical Analytics, aiming to provide real-time data and analyses for intensive care units and operating rooms. Read more
Quanttus pulls in a $19M Series A round for wearable vital signs monitor
February 26, 2014 by Brad Perriello
MIT spinout Quanttus says it added a $19 million Series A round to the $3 million seed round it drummed up last year for its wearable vital signs monitor.
Cambridge, Mass.-based Quanttus said it brought in $19 million in a Series A funding round from Khosla Ventures and Matrix Partners, following a $3 million seed round from Khosla founder Vinod Khosla.
MIT spinout Quanttus is developing a wearable vital signs monitor designed to measure heart rate, respiration and blood pressure that resembles a wristwatch, according to the MIT Technology Review. Read more
Pursuit Vascular nears $1.6M funding goal
February 24, 2014 by Chris Walker
Pursuit Vascular comes within shouting distance of a $1.6 million funding goal for its ClearGuard device for reducing catheter infections.
Pursuit Vascular is close to reaching a $1.6 million funding goal, having raised $1.57 million, according to a regulatory filing.
Minneapolis-based Pursuit Vascular is devleoping technology for reducing catheter infections, including the ClearGuard platform that’s designed to cut infections associated with hemodialysis catheters. Read more
